Literature DB >> 27013545

Minireview: Clinical severity in sickle cell disease: the challenges of definition and prognostication.

Charles T Quinn1.   

Abstract

Sickle cell disease (SCD) is a monogenic, yet highly phenotypically variable disease with multisystem pathology. This manuscript provides an overview of many of the known determinants, modifiers, and correlates of disease severity in SCD. Despite this wealth of data, modeling the variable and multisystem pathology of SCD continues to be difficult. The current status of prediction of specific adverse outcomes and global disease severity in SCD is also reviewed, highlighting recent successes and ongoing challenges.
© 2016 by the Society for Experimental Biology and Medicine.

Entities:  

Keywords:  Biomarkers; disease severity; models; outcomes; phenotype; prediction; prevention; prognosis; sickle cell anemia; sickle cell disease; survival

Mesh:

Substances:

Year:  2016        PMID: 27013545      PMCID: PMC4871738          DOI: 10.1177/1535370216640385

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  62 in total

1.  Association of G6PD with lower haemoglobin concentration but not increased haemolysis in patients with sickle cell anaemia.

Authors:  Mehdi Nouraie; Noel S Reading; Andrew Campbell; Caterina P Minniti; Sohail R Rana; Lori Luchtman-Jones; Gregory J Kato; Mark T Gladwin; Oswaldo L Castro; Josef T Prchal; Victor R Gordeuk
Journal:  Br J Haematol       Date:  2010-05-09       Impact factor: 6.998

2.  Prediction of adverse outcomes in children with sickle cell disease.

Authors:  S T Miller; L A Sleeper; C H Pegelow; L E Enos; W C Wang; S J Weiner; D L Wethers; J Smith; T R Kinney
Journal:  N Engl J Med       Date:  2000-01-13       Impact factor: 91.245

Review 3.  Predicting clinical severity in sickle cell anaemia.

Authors:  M H Steinberg
Journal:  Br J Haematol       Date:  2005-05       Impact factor: 6.998

4.  Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic-based population study.

Authors:  K J Wierenga; I R Hambleton; N A Lewis
Journal:  Lancet       Date:  2001-03-03       Impact factor: 79.321

5.  G6PD deficiency and absence of α-thalassemia increase the risk for cerebral vasculopathy in children with sickle cell anemia.

Authors:  Philippe Joly; Nathalie Garnier; Kamila Kebaili; Céline Renoux; Arthur Dony; Nathalie Cheikh; Cécile Renard; Antony Ceraulo; Daniela Cuzzubbo; Corinne Pondarré; Cyril Martin; Vincent Pialoux; Alain Francina; Yves Bertrand; Philippe Connes
Journal:  Eur J Haematol       Date:  2015-06-30       Impact factor: 2.997

6.  Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2.

Authors:  Lori A Styles; Miguel Abboud; Sandra Larkin; Margaret Lo; Frans A Kuypers
Journal:  Br J Haematol       Date:  2006-11-30       Impact factor: 6.998

7.  The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS).

Authors:  Ersi Voskaridou; Dimitrios Christoulas; Antonios Bilalis; Eleni Plata; Konstantinos Varvagiannis; George Stamatopoulos; Klio Sinopoulou; Aggeliki Balassopoulou; Dimitris Loukopoulos; Evangelos Terpos
Journal:  Blood       Date:  2009-11-10       Impact factor: 22.113

8.  G6PD deficiency, absence of alpha-thalassemia, and hemolytic rate at baseline are significant independent risk factors for abnormally high cerebral velocities in patients with sickle cell anemia.

Authors:  Françoise Bernaudin; Suzanne Verlhac; Sylvie Chevret; Martine Torres; Lena Coic; Cécile Arnaud; Annie Kamdem; Isabelle Hau; Maria Grazia Neonato; Christophe Delacourt
Journal:  Blood       Date:  2008-09-04       Impact factor: 22.113

9.  A network model to predict the risk of death in sickle cell disease.

Authors:  Paola Sebastiani; Vikki G Nolan; Clinton T Baldwin; Maria M Abad-Grau; Ling Wang; Adeboye H Adewoye; Lillian C McMahon; Lindsay A Farrer; James G Taylor; Gregory J Kato; Mark T Gladwin; Martin H Steinberg
Journal:  Blood       Date:  2007-06-28       Impact factor: 22.113

10.  A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia.

Authors:  Jacqueline N Milton; Paola Sebastiani; Nadia Solovieff; Stephen W Hartley; Pallav Bhatnagar; Dan E Arking; Daniel A Dworkis; James F Casella; Emily Barron-Casella; Christopher J Bean; W Craig Hooper; Michael R DeBaun; Melanie E Garrett; Karen Soldano; Marilyn J Telen; Allison Ashley-Koch; Mark T Gladwin; Clinton T Baldwin; Martin H Steinberg; Elizabeth S Klings
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

View more
  26 in total

1.  Association between hospital admissions and healthcare provider communication for individuals with sickle cell disease.

Authors:  Robert M Cronin; Manshu Yang; Jane S Hankins; Jeannie Byrd; Brandi M Pernell; Adetola Kassim; Patricia Adams-Graves; Alexis A Thompson; Karen Kalinyak; Michael DeBaun; Marsha Treadwell
Journal:  Hematology       Date:  2020-12       Impact factor: 2.269

2.  Sickle cell disease severity: an introduction.

Authors:  Betty S Pace; Steven R Goodman
Journal:  Exp Biol Med (Maywood)       Date:  2016-04

3.  Empirically Derived Profiles of Health-Related Quality of Life in Youth and Young Adults with Sickle Cell Disease.

Authors:  Mary E Keenan; Megan Loew; Kristoffer S Berlin; Jason Hodges; Nicole M Alberts; Jane S Hankins; Jerlym S Porter
Journal:  J Pediatr Psychol       Date:  2021-03-18

4.  High molecular weight kininogen contributes to early mortality and kidney dysfunction in a mouse model of sickle cell disease.

Authors:  Erica M Sparkenbaugh; Malgorzata Kasztan; Michael W Henderson; Patrick Ellsworth; Parker Ross Davis; Kathryn J Wilson; Brandi Reeves; Nigel S Key; Sidney Strickland; Keith McCrae; David M Pollock; Rafal Pawlinski
Journal:  J Thromb Haemost       Date:  2020-08-27       Impact factor: 5.824

5.  Red Blood Cell Adhesion to Heme-Activated Endothelial Cells Reflects Clinical Phenotype in Sickle Cell Disease.

Authors:  Erdem Kucukal; Anton Ilich; Nigel S Key; Jane A Little; Umut A Gurkan
Journal:  Am J Hematol       Date:  2018-06-15       Impact factor: 10.047

6.  Influence of Nutrition on Disease Severity and Health-related Quality of Life in Adults with Sickle Cell Disease: A Prospective Study.

Authors:  Sanaa Kamal; Moheyeldeen Mohamed Naghib; Jamaan Al Zahrani; Huda Hassan; Karim Moawad; Omar Arrahman
Journal:  Mediterr J Hematol Infect Dis       Date:  2021-01-01       Impact factor: 2.576

7.  Genetic variants of GCH1 associate with chronic and acute crisis pain in African Americans with sickle cell disease.

Authors:  Nilanjana Sadhu; Ellie H Jhun; Yingwei Yao; Ying He; Robert E Molokie; Diana J Wilkie; Zaijie Jim Wang
Journal:  Exp Hematol       Date:  2018-07-19       Impact factor: 3.084

8.  Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease.

Authors:  Angela E Rankine-Mullings; Shirley Owusu-Ofori
Journal:  Cochrane Database Syst Rev       Date:  2021-03-08

Review 9.  Techniques for the Detection of Sickle Cell Disease: A Review.

Authors:  Wjdan A Arishi; Hani A Alhadrami; Mohammed Zourob
Journal:  Micromachines (Basel)       Date:  2021-05-05       Impact factor: 2.891

10.  Standardized microfluidic assessment of red blood cell-mediated microcapillary occlusion: Association with clinical phenotype and hydroxyurea responsiveness in sickle cell disease.

Authors:  Yuncheng Man; Erdem Kucukal; Ran An; Allison Bode; Jane A Little; Umut A Gurkan
Journal:  Microcirculation       Date:  2021-01-09       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.